CIP-Net Members
UG3 CIP-Net Research Centers
UG3CA290454
Chimeric RNA driven neopeptide vaccine for prevention of breast cancer in germline BRCA1/2 carriers
MD Anderson Cancer Center, University of Houston
PI: Isabelle Bedrosian, MPI: Anjana Bhardwaj, MPI: Preethi Gunaratne
UG3CA290300
Immunosurveillance of breast glands with oncogenic germline mutations
Massachusetts General Hospital
PI: Shadmehr Demehri
UG3CA290443
Investigating novel targets for topical immunoprevention of keratinocytic skin cancer
University Of Arizona
PI: Sally E. Dickinson, MPI: Clara Curiel-Lewandrowski
UG3CA290517
Immune determinants modulating cancer development in Lynch Syndrome
Icahn School of Medicine at Mount Sinai
PI: Nina Bhardwaj, MPI: Aimee Lucas, MPI: Robert Samstein
UG3CA301294
Engineered probiotic bacteria for colorectal cancer immunoprevention and interception
Columbia University Health Sciences
PI: Nicholas Arpaia, MPI: Tal Danino
UG3CA290302
Targeting microbial triggers of gammopathy for immunoprevention
Fred Hutchinson Cancer Center
PI: Madhav Dhodapkar, MPI: Richard Flavell, MPI: Noah Palm
UG3CA290305
Developing a novel agonist of CD137 for cancer immunoprevention
University of Missouri - Columbia
PI: Haval Shirwan, MPI: Esma Yolcu
UG3CA290468
Preclinical studies for the immunoprevention of multiple myeloma
Mayo Clinic Arizona
PI: Peter Leif Bergsagel, MPI: Marta Chesi
CIP-Net Coordinating Center
U24CA305623
Cancer Immunoprevention Network (CIP-Net) Data and Resource Coordinating Center
Roswell Park Comprehensive Cancer Center, Massachusetts General Hospital
PI: Alan Hutson, MPI: Song Liu, MPI: Shadmehr Demehri
CIP-Net Patient Advocates
Nicole Black
Behavioral Health Consultant
University of Missouri
Eric Blackburn
Leader, Veterans with Myeloma
Special Interest Group
Bodour Salhia, PhD
Professor, Interim Chair, Department of Biology, Royce and Mary Trotter Chair in Cancer Research, Keck School of Medicine of University of Southern California
Multiple Myeloma Survivor
Founder of The Bench with Bedside Initiative
NCI CIP-Net Program Leadership
Altaf Mohammed, Ph.D.
NCI Division of Cancer Prevention,
Chemopreventive Agent Development Research Group
Lillian Kuo, Ph.D.
NCI Division of Cancer Biology,
Cancer Immunology, Hematology, and Etiology Branch
CIP-Net Associate Members
Dr. Matteo Bellone
San Raffaele Scientific Institute and Fondazione Centro San Raffaele
Dr. Jason Marshall
Frederick National Laboratory, NCI
Dr. Urvi Shah
Memorial Sloan Kettering
Dr. Yurong Song
Frederick National Laboratory, NCI